摘要
目的观察双黄连口服液(仅适用于儿童)治疗小儿EB病毒感染58例的临床治疗效果,以期提高临床诊治水平。方法选取自我院2016年3月至2017年2月进行治疗的EB病毒感染的患儿,共58例,根据治疗方法的不同,将其分为双黄连组和更昔洛韦组,各29例,双黄连组给予双黄连口服液(仅适用于儿童)进行治疗,按照患儿年龄的不同,口服剂量如下:1~3岁1次10 mL;4~7岁1次20 mL;每日3次;更昔洛韦组给予更昔洛韦静脉滴注进行治疗,其他基础治疗两组相同,对比两组的临床治疗效果。结果双黄连组和更昔洛韦组治疗的总有效率分别为95.83%.77.08%。经分析:X^2=8.24,P=0.041,P<0.05,具有统计学意义。结论临床上使用双黄连口服液(仅适用于儿童)治疗小儿EB病毒感染,痊愈率高,且服用方便,值得在临床上推广应用。
Objective To observe the clinical effect of Shuanghuanglian oral liquid（only for children） in the treatment of 58 children with EB virus infection,so as to improve the level of clinical diagnosis and treatment. Methods From February 2017 to March 2016 the self treatment of EB virus infection in children, a total of 58 cases, according to the different treatment methods, which can be divided into Shuanghuanglian group and Ganciclovir group, 29 cases in each group were treated with Shuanghuanglian, Shuanghuanglian oral liquid（only for children） were treated according to different age children the oral dose is as follows： 1-3 years old, a 10 mL; a 20 mL 4-7 years old; 3 times a day; Ganciclovir group received intravenous Ganciclovir treatment, other treatments were similar in two groups. The clinical efficacy was compared between two groups. Results The total effective rate of Shuanghuanglian group and Ganciclovir group was 95.83% and 77.08% respectively. After analysis： X2=8.24, P=0.041, P〈0.05, statistical significance. Conclusion Shuanghuanglian oral liquid（only suitable for children） is effective in the treatment of EB infection in children. It has a high cure rate and is easy to take. It is worth popularizing in clinic.
出处
《中国医药指南》
2017年第28期20-21,共2页
Guide of China Medicine
